← Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Press Releases
Date | Press release |
---|---|
2024-09-30 17:15:00 | Seres Therapeutics Announces Completion Of Vowst™ Asset Sale To SociÉtÉ Des Produits NestlÉ S.a Transaction supports further development of ser-155, following recent promising clinical data, and other cultivated live biotherapeutics, for multiple medically vulnerable patient populations at high risk of life-threatening bacterial infections |
2024-09-27 15:26:00 | Seres Therapeutics Stockholders Issue Open Letter To Board Of Directors Regarding Reported Engagement With NestlÉ Geneva--(business wire)--lucien selce and mkt capital ltd. (together, “we”), who collectively own 1.4 million shares of seres therapeutics inc. (nasdaq: mcrb) (“seres” or the “company”), today published the following open letter to the company’s board of directors (the “board”). *** september 27, 2024 members of the board, we are writing to you today as a stockholder of seres who is seeking additional information regarding the company’s planned sale of its vowst business to nestlÉ health scienc. |
2024-08-06 07:00:00 | Seres Therapeutics Announces Signing Of Vowst™ Asset Purchase Agreement With NestlÉ Health Science Upon closing, seres to receive $175m cash infusion, including an upfront payment, prepayment of a future commercial milestone payment, and an equity investment in seres common stock, less approximately $20m in settlement of net obligations between the parties; anticipated deal closing in the next 90 days |
2024-06-06 07:00:00 | NestlÉ Health Science Agrees To Acquire Global Rights To Vowst®, Product It Launched In June 2023 Transaction ensures nestlÉ health science will continue to commercialize the product bridgewater, n.j. , june 6, 2024 /prnewswire/ -- seres therapeutics, inc. (nasdaq: mcrb), announced today that it has agreed to a non-binding memorandum of understanding with nestlÉ health science in which nestlÉ health science will acquire certain tangible and intangible assets associated with vowst (fecal microbiota spores, live-brpk) capsules. |